Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Analysis and Commentary STEVEN GROSSMAN 6/30/17 Analysis and Commentary STEVEN GROSSMAN 6/30/17 Happier ... But Not Out of the Woods by Any Means Read More Analysis and Commentary STEVEN GROSSMAN 6/23/17 Analysis and Commentary STEVEN GROSSMAN 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More Analysis and Commentary STEVEN GROSSMAN 6/16/17 Analysis and Commentary STEVEN GROSSMAN 6/16/17 From Fantasy to a Potential Reality ... Maybe? Read More Analysis and Commentary STEVEN GROSSMAN 6/9/17 Analysis and Commentary STEVEN GROSSMAN 6/9/17 The Realities of the FY 18 Budget; Some Qs&As Read More Analysis and Commentary STEVEN GROSSMAN 5/31/17 Analysis and Commentary STEVEN GROSSMAN 5/31/17 How the Federal Budget Applies to the FDA -- A Refresher for FY 18 Read More Analysis and Commentary STEVEN GROSSMAN 5/26/17 Analysis and Commentary STEVEN GROSSMAN 5/26/17 The Good News; the Bad News; and What's Next? Read More Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More Analysis and Commentary STEVEN GROSSMAN 5/5/17 Analysis and Commentary STEVEN GROSSMAN 5/5/17 Time for Some Heartfelt "Thank you"s Read More Analysis and Commentary STEVEN GROSSMAN 4/28/17 Analysis and Commentary STEVEN GROSSMAN 4/28/17 Success ... But More Work Will Be Needed! Read More Analysis and Commentary STEVEN GROSSMAN 4/21/17 Analysis and Commentary STEVEN GROSSMAN 4/21/17 Now Is the Time for YOU to Take Action, PLEASE Read More Analysis and Commentary STEVEN GROSSMAN 4/14/17 Analysis and Commentary STEVEN GROSSMAN 4/14/17 Congress Doesn't "Dispose" in a Vacuum Read More Analysis and Commentary STEVEN GROSSMAN 4/7/17 Analysis and Commentary STEVEN GROSSMAN 4/7/17 Help Us to Deliver Some Specific Messages to Congress Read More Analysis and Commentary STEVEN GROSSMAN 3/31/17 Analysis and Commentary STEVEN GROSSMAN 3/31/17 President Trump's FY 18 Proposed Budget: More Qs and More As Read More Analysis and Commentary STEVEN GROSSMAN 3/24/17 Analysis and Commentary STEVEN GROSSMAN 3/24/17 Ag/FDA Appropriations Subcommittees Need to Hear From Entire Stakeholder Community Read More Analysis and Commentary STEVEN GROSSMAN 3/17/17 Analysis and Commentary STEVEN GROSSMAN 3/17/17 President Trump's FY 18 Proposed Budget: Some Qs and Some As Read More Analysis and Commentary STEVEN GROSSMAN 3/11/17 Analysis and Commentary STEVEN GROSSMAN 3/11/17 From "Hibernation" to Avoidance of Confusion Read More Analysis and Commentary STEVEN GROSSMAN 3/3/17 Analysis and Commentary STEVEN GROSSMAN 3/3/17 Guns, Butter, and the Uniqueness of the FDA Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More
Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More
Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Analysis and Commentary STEVEN GROSSMAN 6/30/17 Analysis and Commentary STEVEN GROSSMAN 6/30/17 Happier ... But Not Out of the Woods by Any Means Read More
Analysis and Commentary STEVEN GROSSMAN 6/23/17 Analysis and Commentary STEVEN GROSSMAN 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More
Analysis and Commentary STEVEN GROSSMAN 6/16/17 Analysis and Commentary STEVEN GROSSMAN 6/16/17 From Fantasy to a Potential Reality ... Maybe? Read More
Analysis and Commentary STEVEN GROSSMAN 6/9/17 Analysis and Commentary STEVEN GROSSMAN 6/9/17 The Realities of the FY 18 Budget; Some Qs&As Read More
Analysis and Commentary STEVEN GROSSMAN 5/31/17 Analysis and Commentary STEVEN GROSSMAN 5/31/17 How the Federal Budget Applies to the FDA -- A Refresher for FY 18 Read More
Analysis and Commentary STEVEN GROSSMAN 5/26/17 Analysis and Commentary STEVEN GROSSMAN 5/26/17 The Good News; the Bad News; and What's Next? Read More
Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More
Analysis and Commentary STEVEN GROSSMAN 5/5/17 Analysis and Commentary STEVEN GROSSMAN 5/5/17 Time for Some Heartfelt "Thank you"s Read More
Analysis and Commentary STEVEN GROSSMAN 4/28/17 Analysis and Commentary STEVEN GROSSMAN 4/28/17 Success ... But More Work Will Be Needed! Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/17 Analysis and Commentary STEVEN GROSSMAN 4/21/17 Now Is the Time for YOU to Take Action, PLEASE Read More
Analysis and Commentary STEVEN GROSSMAN 4/14/17 Analysis and Commentary STEVEN GROSSMAN 4/14/17 Congress Doesn't "Dispose" in a Vacuum Read More
Analysis and Commentary STEVEN GROSSMAN 4/7/17 Analysis and Commentary STEVEN GROSSMAN 4/7/17 Help Us to Deliver Some Specific Messages to Congress Read More
Analysis and Commentary STEVEN GROSSMAN 3/31/17 Analysis and Commentary STEVEN GROSSMAN 3/31/17 President Trump's FY 18 Proposed Budget: More Qs and More As Read More
Analysis and Commentary STEVEN GROSSMAN 3/24/17 Analysis and Commentary STEVEN GROSSMAN 3/24/17 Ag/FDA Appropriations Subcommittees Need to Hear From Entire Stakeholder Community Read More
Analysis and Commentary STEVEN GROSSMAN 3/17/17 Analysis and Commentary STEVEN GROSSMAN 3/17/17 President Trump's FY 18 Proposed Budget: Some Qs and Some As Read More
Analysis and Commentary STEVEN GROSSMAN 3/11/17 Analysis and Commentary STEVEN GROSSMAN 3/11/17 From "Hibernation" to Avoidance of Confusion Read More
Analysis and Commentary STEVEN GROSSMAN 3/3/17 Analysis and Commentary STEVEN GROSSMAN 3/3/17 Guns, Butter, and the Uniqueness of the FDA Read More
